RECRUITING

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

Description

This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment

Conditions

Staphylococcal Aureus InfectionMicrobial ColonizationPediatric InfectionS. Aureus ColonizationMicrobial Transplant
Talk to us

Related Conditions:

Staphylococcal Aureus InfectionMicrobial ColonizationPediatric InfectionS. Aureus ColonizationMicrobial Transplant

Study Overview

On this page

Study Details

Study overview

This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment

Parent-to-Child Nasal Microbiota Transplant to Reestablish Nasal Microbiome Diversity After Intranasal Mupirocin Treatment of Children With Staphylococcus Aureus Nasal Colonization

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

Condition
Staphylococcal Aureus Infection
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21287

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    0 Years to 60 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Johns Hopkins University,

    Aaron M Milstone, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

    Study Record Dates

    2028-01-01